Brain imaging in women with chronic pain or opioid use
Compares brain activity in women with chronic pain or opioid use and healthy women.
Key facts
- Who runs it
- Duke University
- Where
- Durham, United StatesSee the site
- Trial code
- Registry title
- Neuroimaging of Opioid Phase (OPAL)
- Status
- Recruiting
- People taking part
- 140 people, planned
- Started
- 1 Jun 2023
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Opioid Phase
- Record updated
- 3 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with chronic pain, with or without opioid use, and healthy women. It compares brain activity between these groups.
- Age
- 18 years and older
- Sex
- Female only
- Disease stage
- Patients: fibromyalgia and/or chronic pain, diagnosed by a doctor or self-reported. Healthy volunteers: no chronic pain now or in the past.
- Earlier treatment
- Opioid group: currently taking opioid medicines. Non-opioid patient group: not using opioid medicines. Healthy volunteers: no opioid use and no regular pain-relieving or mood-altering medicines.
Main reasons for not taking part
- Men
- Cannot have an MRI scan
- Limited ability to fully take part in tasks and follow-up visits
- Other factors that the researchers judge could harm the person or the study
- Cannot read or understand English, or cannot give consent
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- female and ages 18+
- ability to read/understand English and give consent to participate
- no current or history of chronic pain
- not regularly taking any pain-relieving or mood-altering medications (per PI discretion)
- absence of use of opioid medications
- female and ages 18 +
- ability to read/understand English and give consent to participate
- self-reported or physician diagnosis of fibromyalgia and/or chronic pain
- current use of opioid medication(s) for inclusion in the opioid patient group -OR- absence of use of opioid medications for inclusion in the non-opioid patient group
Who cannot take part
- limited ability to participate fully in behavioral tasks, longitudinal follow-up
- MRI contraindication
- any factors that at the discretion of the investigators would adversely affect the participant or the integrity of the study
- male
Where in United States
- Duke University Medical CenterDurham, United StatesContact: HAPN Lab ManagerTaking people
About the trial
What the trial wants to find out
The purpose of this study is to compare activity in the brains of female adults with chronic pain and/or opioid use, and healthy female adults that may help to develop new and targeted treatments for adults with chronic pain and alternatives to opioid therapy.
The 3 groups in the trial
- Female adults with chronic pain who take prescribed opioid medicationsTreatment being tested
Opioid taking participants will undergo two study visits, one for each opioid phase ("peak" or "trough")
Treatment: Opioid Phase
- Female adults with chronic pain who do not take opioid medicationsNo study treatment, for comparison
Participants with chronic pain who are not taking opioids will undergo one study visit
- Healthy controlsNo study treatment, for comparison
Healthy female participants who are not taking opioids will undergo one study visit
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Neurobiological Consequences of Long-Term Opioid Therapy in the Brain and Spinal Cord
- Plain-language title
- Brain imaging in women with chronic pain or opioid useGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Reduced trapezius pressure pain threshold in fibromyalgia and opioid use.The journal of pain, 2025
- Record updated
- 3 June 2026